|
|
Volumn 8, Issue 1, 2001, Pages 119-125
|
|
Radiotherapy combined with transcatheter arterial infusion of cisplatin versus oral fluoropyrimidine anticancer agent for locally advanced carcinoma of the uterine cervix: A prospective follow-up study
|
|
Author keywords
Chemoradiothcrapy; Cisplatin; Locally advanced cervical cancer; Oral fluoropyrimidine
|
|
Indexed keywords
1 UFT PROTOCOL;
1-UFT PROTOCOL;
ALKYLATING AGENT;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
CISPLATIN;
FLUOROURACIL;
TEGAFUR;
URACIL;
ADENOCARCINOMA;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
COHORT ANALYSIS;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE FREE SURVIVAL;
FEMALE;
FOLLOW UP;
HUMAN;
INTRAARTERIAL DRUG ADMINISTRATION;
LIFE TABLE;
MIDDLE AGED;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
ORAL DRUG ADMINISTRATION;
PATHOLOGY;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
SQUAMOUS CELL CARCINOMA;
SURVIVAL;
TREATMENT OUTCOME;
UTERINE CERVIX TUMOR;
ADENOCARCINOMA;
ADMINISTRATION, ORAL;
ADULT;
AGED;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, SQUAMOUS CELL;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
COHORT STUDIES;
COMBINED MODALITY THERAPY;
DISEASE-FREE SURVIVAL;
FEMALE;
FLUOROURACIL;
FOLLOW-UP STUDIES;
HUMANS;
INFUSIONS, INTRA-ARTERIAL;
LIFE TABLES;
MIDDLE AGED;
PROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
TEGAFUR;
TREATMENT OUTCOME;
URACIL;
UTERINE CERVICAL NEOPLASMS;
|
|
EID: 0035219975
PISSN: 1021335X
EISSN: None
Source Type: Journal
DOI: 10.3892/or.8.1.119 Document Type: Article |
|
Times cited : (6)
|
|
References (2)
|
